Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04038489
Title COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer (Breast 51)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Virginia
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.